Platelets and prostaglandins in coronary artery disease. Rationale for use of platelet-suppressive drugs.
D000818:Animals; D001161:Arteriosclerosis / Q000097:blood; D001241:Aspirin / Q000494:pharmacology; D001792:Blood Platelets / Q000187:drug effects* / Q000378:metabolism; D002986:Clinical Trials as Topic; D003327:Coronary Disease / Q000097:blood* / Q000188:drug therapy; D004176:Dipyridamole / Q000494:pharmacology; D004285:Dogs; D006801:Humans; D008954:Models, Biological; D010974:Platelet Aggregation / Q000187:drug effects*; D011453:Prostaglandins / Q000097:blood*; D013442:Sulfinpyrazone / Q000494:pharmacology
D011453:Prostaglandins; D004176:Dipyridamole; D001241:Aspirin; D013442:Sulfinpyrazone